Filing Details
- Accession Number:
- 0001104659-21-046654
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-05 17:14:30
- Reporting Period:
- 2021-04-01
- Accepted Time:
- 2021-04-05 17:14:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1744659 | Akero Therapeutics Inc. | AKRO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1778739 | Richard William White | C/O Akero Therapeutics, Inc. 601 Gateway Boulevard, Suite 350 South San Francisco CA 94080 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-04-01 | 50,000 | $7.01 | 52,270 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-04-01 | 48,851 | $28.63 | 3,419 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2021-04-01 | 1,149 | $29.29 | 2,270 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2021-04-01 | 50,000 | $0.00 | 50,000 | $7.01 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 364,029 | 2029-04-04 | No | 4 | M | Direct |
Footnotes
- Shares sold pursuant to a Rule 10b5-1 trading plan dated October 5, 2020, as amended on November 18, 2020 previously adopted by the Reporting Person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $28.25 to $29.18, inclusive.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $29.25 to $29.35, inclusive.
- 25% of this option vested on April 1, 2020, and the remaining 75% of this option shall vest in 36 equal monthly installments thereafter.
Billionaire Hedge Funds
